ACCS
ACCESS Newswire Inc.
ACCS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
META
Meta Platforms, Inc.
META has the edge over ACCS overall, supported by stronger valuation and lower modeled downside.
ACCS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Strong |
ACCS's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is under pressure.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ACCS PE Valuation
ACCS has no meaningful PE right now: it lost money over the past year.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
ACCS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect ACCS's earnings to grow and its profitability to improve, with its revenue holding steady.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
ACCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | — |
| Q3 2026 | -$0.46 | +$0.93 |
| Q2 2026 | -$0.45 | +$1.05 |
| Q1 2026 | -$0.45 | +$0.93 |
| Q4 2025 | $1.11 | +$3.93 |
| Q3 2025 | -$1.39 | -$1.04 |
| Q2 2025 | -$1.50 | -$1.34 |
| Q1 2025 | -$1.38 | -790% |
| Q4 2024 | -$2.82 | -1510% |
ACCS is still losing money, but far less than before: $0.46 per share over the past year, against $2.82 at its worst in late 2024.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over ACCS on earnings quality, reporting a profit while its opponent remains loss making.
ACCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.5M | -3.6% |
| Q2 2026 | $5.6M | -0.1% |
| Q1 2026 | $5.3M | -2.7% |
| Q4 2025 | $5.8M | +299% |
| Q3 2025 | $5.7M | -18% |
| Q2 2025 | $5.6M | -27% |
| Q1 2025 | $5.5M | -21% |
| Q4 2024 | $1.5M | -81% |
ACCS's revenue is growing: $6M last quarter, down 3.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.6% | +0.7 points |
| Q2 2026 | -5.5% | -1 points |
| Q1 2026 | -13% | -1.1 points |
| Q4 2025 | -13% | +1139 points |
| Q3 2025 | -3.2% | -5.5 points |
| Q2 2025 | -4.4% | -8.8 points |
| Q1 2025 | -12% | -12 points |
| Q4 2024 | -1152% | -1150 points |
ACCS's operating margin was −2.6% last quarter, up 0.7 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over ACCS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over ACCS on profitability, with a higher operating margin.
ACCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $469K | +$1.1M |
| Q2 2026 | $160K | +19% |
| Q1 2026 | $862K | +17% |
| Q4 2025 | $258K | -70% |
| Q3 2025 | -$590K | -139% |
| Q2 2025 | $135K | +$325K |
| Q1 2025 | $735K | -24% |
| Q4 2024 | $866K | +12% |
ACCS has the edge over META on cash flow, with more consistent year-over-year improvement.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
ACCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -43K shares |
| 1 year | -1% | -38K shares |
ACCS has the edge over META on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $437,000 |
| Q2 2026 | $302,000 |
| Q1 2026 | $29,000 |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
ACCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2024 | 3.8x | Elevated |
| Q2 2024 | 3.7x | Elevated |
| Q1 2024 | 2.6x | Moderate |
| Q4 2023 | 2.5x | Moderate |
ACCS has the edge over META on leverage, with a lower net debt burden relative to earnings.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
ACCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 4.2 | Oversold |
ACCS's weekly RSI is 28 (oversold) and its Stochastic is 4 (oversold).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
ACCS PE vs Communication Services Sector
| Metric | ACCS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
ACCS has no meaningful PE right now: it lost money over the past year.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
ACCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.18 | 17% below |
| 20 week MA | $5.27 | 34% below |
| 50 week MA | $6.81 | 49% below |
| 100 week MA | $8.41 | 59% below |
| 200 week MA | $12.0 | 71% below |
ACCS is in a downtrend: it's below all five of its weekly moving averages, and 71% below its 200-week average.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has the edge over ACCS on trend strength, trading above more of its moving averages.
ACCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $19.5 | +70% |
| 2021 | $19.5 | $30.5 | +56% |
| 2022 | $30.5 | $25.0 | -18% |
| 2023 | $25.0 | $18.1 | -27% |
| 2024 | $18.1 | $8.77 | -52% |
| 2025 | $8.77 | $8.58 | -2.2% |
| 2026 YTD | $8.58 | $3.49 | -59% |
ACCS has finished four years in a row lower, and it's down 59% so far in 2026.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over ACCS on returns for 2026, with the stronger performance.